E-LIB Suche - Ergebnisse für: Penkov, K.

1

Complete blood count inflammatory indexes as a potential pr..:

Zakharenkova, O. ; Penkov, K. ; Vasilev, A..
Clinica Chimica Acta. 558 (2024) - p. 118927 , 2024

Link: https://doi.org/10.1016/..

2

114M0 First-line cemiplimab for locally advanced non-small ..:

Kalinka, E. ; Bondarenko, I. ; Gogishvili, M....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S106 , 2023

Link: https://doi.org/10.1016/..

3

50 Cemiplimab plus chemotherapy versus chemotherapy alone i..:

Makharadze, T. ; Gogishvili, M. ; Melkadze, T....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S38-S39 , 2023

Link: https://doi.org/10.1016/..

4

Extended follow-up from JAVELIN Renal 101: subgroup analysi..:

Haanen, J.B.A.G. ; Larkin, J. ; Choueiri, T.K....
ESMO Open. 8 (2023) 3 - p. 101210 , 2023

Link: https://doi.org/10.1016/..

5

A phase Ib/II dose expansion study of subcutaneous sasanlim..:

Cho, B.C. ; Penkov, K. ; Bondarenko, I....
ESMO Open. 8 (2023) 4 - p. 101589 , 2023

Link: https://doi.org/10.1016/..

6

P1.11-01 Cobolimab with Dostarlimab and Docetaxel in Patien..:

Kim, H.R. ; Gridelli, C. ; Kapur, D....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S109-S110 , 2022

Link: https://doi.org/10.1016/..

7

122MO Cemiplimab (cemi) + platinum doublet chemotherapy (ch..:

Baramidze, A. ; Gogishvili, M. ; Melkadze, T....
Immuno-Oncology and Technology. 16 (2022) - p. 100234 , 2022

Link: https://doi.org/10.1016/..

8

181P SELECT: A phase II randomized trial evaluating 2 doses..:

Gumus, M. ; Sukalinskaya, A. ; Andric, Z.G....
Immuno-Oncology and Technology. 16 (2022) - p. 100293 , 2022

Link: https://doi.org/10.1016/..

9

System for materials testing at static loading:

Tsonev, V ; Kuzmanov, N ; Borisov, B.
IOP Conference Series: Materials Science and Engineering. 618 (2019) 1 - p. 012048 , 2019

Link: https://doi.org/10.1088/..

10

248. Breast recurrence after conservative surgery in patien..:

Semiglazov, V.F. ; Paltuev, R.M. ; Bozhok, A.A....
European Journal of Surgical Oncology. 38 (2012) 9 - p. 813 , 2012

Link: https://doi.org/10.1016/..

11

P181 Factors influencing prognosis in node-negative early b..:

Semiglazov, V.F. ; Paltuev, R.M. ; Nikitina, I.V....
The Breast. 20 (2011) - p. S39 , 2011

Link: https://doi.org/10.1016/..

12

A phase Ib/II dose expansion study of subcutaneous sasanlim..:

Cho, B ; Penkov, K ; Bondarenko, I...
qt6r54g8vf. , 2023

Link: https://escholarship.org..

13

Extended follow-up from JAVELIN Renal 101: subgroup analysi..:

Haanen, J.B.A.G ; Larkin, J ; Choueiri, T.K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265611/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Post Hoc Analysis of Lorlatinib Intracranial Efficacy and S..:

Solomon, BJ ; Bauer, TM ; Ou, S-HI...
issn:0732-183X. , 2022

Link: http://hdl.handle.net/11..

15

Efficacy and Safety of Rovalpituzumab Tesirine Compared Wit..:

Blackhall, Fiona ; Jao, K ; Greillier, L...
Journal of Thoracic Oncology. , 2021

Link: https://ddd.uab.cat/reco..